These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture. Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938 [TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological development of steroidal inhibitors of aromatase. Brueggemeier RW; Li PK; Chen HH; Moh PP; Katlic NE J Steroid Biochem Mol Biol; 1990 Nov; 37(3):379-85. PubMed ID: 2257241 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors. Li PK; Brueggemeier RW J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006 [TBL] [Abstract][Full Text] [Related]
5. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships. Numazawa M; Yamaguchi S J Steroid Biochem Mol Biol; 1998 Oct; 67(1):41-8. PubMed ID: 9780028 [TBL] [Abstract][Full Text] [Related]
6. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships. Numazawa M; Oshibe M J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709 [TBL] [Abstract][Full Text] [Related]
7. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs. Numazawa M; Shelangouski M; Nagasaka M Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. O'Reilly JM; Li N; Duax WL; Brueggemeier RW J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845 [TBL] [Abstract][Full Text] [Related]
12. 7-substituted 1,4,6-androstatriene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase. Li PK; Brueggemeier RW J Steroid Biochem; 1990 Aug; 36(6):533-9. PubMed ID: 2214770 [TBL] [Abstract][Full Text] [Related]
13. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain. Numazawa M; Oshibe M Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors. Numazawa M; Yamaguchi S Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379 [TBL] [Abstract][Full Text] [Related]
16. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group. Numazawa M; Oshibe M; Yamaguchi S; Tachibana M J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338 [TBL] [Abstract][Full Text] [Related]
18. Steroidal inhibitors as chemical probes of the active site of aromatase. Brueggemeir RW; Moh PP; Ebrahimian S; Darby MV J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):357-65. PubMed ID: 8476749 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis. Brueggemeier RW; Floyd EE; Counsell RE J Med Chem; 1978 Oct; 21(10):1007-11. PubMed ID: 722711 [TBL] [Abstract][Full Text] [Related]